Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart

• Main Authors: Christian Klopsch (Author), Anna Skorska (Author), Marion Ludwig (Author), Heiko Lemcke (Author), Gabriela Maass (Author), Ralf Gaebel (Author), Martin Beyer (Author), Cornelia Lux (Author), Anita Toelk (Author), Karina Müller (Author), Christian Maschmeier (Author), Sarah Rohde (Author), Petra Mela (Author), Brigitte Müller-Hilke (Author), Stefan Jockenhoevel (Author), Brigitte Vollmar (Author), Robert Jaster (Author), Robert David (Author), Gustav Steinhoff (Author)
• Format: Book
• Published: The Company of Biologists, 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ischemic heart failure is the leading cause of mortality worldwide. An early boost of intracardiac regenerative key mechanisms and angiogenetic niche signaling in cardiac mesenchymal stem cells (MSCs) could improve myocardial infarction (MI) healing. Epicardial erythropoietin (EPO; 300 U kg−1) was c...